Intravesical treatment of painful bladder syndrome: A systematic review and Meta-analysis

International Urogynecology Journal

Volumn 23, Issue 9, 2012, Pages 1147-1153

  Matsuoka, P K ^a,b   Haddad, J M ^a   Pacetta, A M ^a   Baracat, E C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Interstitial Cystitis; Intravesical administration; Painful bladder syndrome; Treatment

Indexed keywords

EID: 84868359995     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1686-2     Document Type: Review

References (25)

1. Nickel JC (2004) Interstitial cystitis: a chronic pelvic pain syndrome. Med Clin North Am 88:467-481, xii
2. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol 79:168-171
3. Barbalias GA, Liatsikos EN, Athanasopoulos A, Nikiforidis G (2000) Interstitial cystitis: bladder training with intravesical oxybutynin. J Urol 163:1818-1822
4. Andersson KE (2002) Treatment of the overactive bladder: possible central nervous system drug targets. Urology 59:18-24
5. Jasmin L, Janni G, Manz HJ, Rabkin SD (1998) Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Neurosci 18:10016-10029
6. Marchand JE, Sant GR, Kream RM (1998) Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 81:224-228
7. Fowler CJ (2002) Bladder afferents and their role in the overactive bladder. Urology 59:37-42
8. Wein AJ, Hanno PM (2002) Targets for therapy of the painful bladder. Urology 59:68-73
9. Chen TY, Corcos J, Camel M, Ponsot Y, le Tu M (2005) Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct 16:293-297
10. Goldstein HB, Safaeian P, Garrod K, Finamore PS, Kellogg-Spadt S, Whitmore KE (2008) Depression, abuse and its relationship to interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 19:1683-1686
11. Mayer R, Propert KJ, Peters KM et al (2005) A randomized controlled trial of intravesical Bacillus Calmette-Guerin for treatment refractory interstitial cystitis. J Urol 173:1186-1191
12. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr (1999) The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 161:553-557
13. Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140:203-206
14. Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 104:657-661
15. Locali RF, Buffolo E, Palma JH (2006) Use of aprotinin in thoracic aortic operations associated with deep hypothermic circulatory arrest: a meta-analysis. Rev Bras Cir Cardiovasc 21:377-385
16. Locali RF, Buffolo E, Catani R (2006) Radial artery versus saphenous vein to myocardial revascularization: meta-analysis (there is no statistically significant difference). Rev Bras Cir Cardiovasc 21:255-261
17. Locali RF, Matsuoka PK, Cherbo T, Gabriel EA, Buffolo E (2010) Should biatrial heart transplantation still be performed?: a metaanalysis. Arq Bras Cardiol 94:829-840
18. Hochman B, Locali RF, Matsuoka PK, Ferreira LM (2008) Intralesional triamcinolone acetonide for keloid treatment: a systematic review. Aesthetic Plast Surg 32:705-709
19. Phillips B, Ball C, Sackett D et al (2009) Oxford Centre for evidence-based medicine-levels of evidence. Oxford: University of Oxford, CEBM. Available at: http://www.cebm.net/index.aspx?o01025
20. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
21. Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG (2009) Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 103:910-918
22. Payne CK, Mosbaugh PG, Forrest JB et al (2005) Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173:1590-1594
23. Irani D, Heidari M, Khezri AA (2004) The efficacy and safety of intravesical Bacillus-Calmette-Guerin in the treatment of female patients with interstitial cystitis: a double-blinded prospective placebo controlled study. Urol J 1:90-93
24. Dawson TE, Jamison J (2007) Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev. doi:10.1002/ 14651858. CD006113.pub2
25. Higgins J, Thompson S, Deeks J, Altman D (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560